Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights
Abstract A large body of evidence suggests that mesenchymal stromal cells (MSCs) are able to respond rapidly to the cytokine milieu following systemic infusion. This encounter has the potential to dictate their therapeutic efficacy (also referred to as licensing). MSCs are able to rapidly react to c...
Saved in:
Main Authors: | Akram Hoseinzadeh, Seyed-Alireza Esmaeili, Reza Sahebi, Anahita Madani Melak, Mahmoud Mahmoudi, Maliheh Hasannia, Rasoul Baharlou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-025-04158-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enucleated bone marrow-derived mesenchymal stromal cells regulate immune microenvironment and promote testosterone production through efferocytosis
by: Lu Sun, et al.
Published: (2025-02-01) -
IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury
by: Liwu Zeng, et al.
Published: (2025-02-01) -
The unique activity of the bone morphogenetic protein TGH4 affects the embryonic development of Trichinella spiralis and the establishment of vaccine protection
by: Wenjie Shi, et al.
Published: (2025-02-01) -
Efferocytosis and inflammation: a bibliometric and systematic analysis
by: Xin Cao, et al.
Published: (2025-02-01) -
COVID-19: Impact in endothelial function and therapy with Mesenchymal Stromal Cells
by: Carla Longo de Freitas, et al.
Published: (2021-12-01)